10-Q Filing

GUIDED THERAPEUTICS INC CIK: 924515 Q1 2014

Filing Information

Form Type	10-Q
Accession Number	`0001121781-14-000134`
Period End Date	20140331
Filing Date	20140515
Fiscal Year	2014
Fiscal Period	Q1
XBRL Instance	gthp-20140331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 74 Income Statement 40 Cash Flow Statement 56

Balance Sheet 74 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$613.00K	USD	Point-in-time
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$18.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.04M	USD	Point-in-time
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$18.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$50.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.11M	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$184.00K	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$120.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $18 at both March 31, 2014 and December 31, 2013	`AccountsReceivableNet`	$133.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $18 at both March 31, 2014 and December 31, 2013	`AccountsReceivableNet`	$122.00K	USD	Point-in-time
Inventory, net of reserves of $120 and $184, at March 31, 2014 and December 31, 2013, respectively	`InventoryNetOfReservesOf64And0AtDecember312011And2010Respectively`	$1.25M	USD	Point-in-time
Inventory, net of reserves of $120 and $184, at March 31, 2014 and December 31, 2013, respectively	`InventoryNetOfReservesOf64And0AtDecember312011And2010Respectively`	$1.19M	USD	Point-in-time
Series B convertible preferred stock par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Series B convertible preferred stock par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$48.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$101.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.47M	USD	Point-in-time
Series B convertible preferred stock shares authorized	`PreferredStockSharesAuthorized`	3.00	shares	Point-in-time
Series B convertible preferred stock shares authorized	`PreferredStockSharesAuthorized`	3.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$2.04M	USD	Point-in-time
Series B convertible preferred stock, Issued	`PreferredStockSharesIssued`	2.00	shares	Point-in-time
Series B convertible preferred stock, Issued	`PreferredStockSharesIssued`	2.00	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$920.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$807.00K	USD	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$315.00K	USD	Point-in-time
Series B convertible preferred stock, Outstanding	`PreferredStockSharesOutstanding`	2.00	shares	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$356.00K	USD	Point-in-time
Series B convertible preferred stock, Outstanding	`PreferredStockSharesOutstanding`	2.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$1.28M	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$1.12M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$3.32M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$2.60M	USD	Point-in-time
Common stock, Authorized	`CommonStockSharesAuthorized`	145,000.00	shares	Point-in-time
Common stock, Authorized	`CommonStockSharesAuthorized`	145,000.00	shares	Point-in-time
Common stock, Issued	`CommonStockSharesIssued`	71,770.00	shares	Point-in-time
Common stock, Issued	`CommonStockSharesIssued`	70,479.00	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	70,479.00	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	71,770.00	shares	Point-in-time
Short-term notes payable	`ShorttermNotesPayable`	$378.00K	USD	Point-in-time
Short-term notes payable	`ShorttermNotesPayable`	$35.00K	USD	Point-in-time
Current portion of long-term note payable	`ShortTermBorrowings`	$111.00K	USD	Point-in-time
Current portion of long-term note payable	`ShortTermBorrowings`	$109.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$891.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.27M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$723.00K	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$997.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$6.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$14.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.76M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.77M	USD	Point-in-time
Warrants, at fair value	`WarrantsNotSettleableInCashFairValueDisclosure`	$1.55M	USD	Point-in-time
Warrants, at fair value	`WarrantsNotSettleableInCashFairValueDisclosure`	$1.01M	USD	Point-in-time
Long-term debt payable, less current portion	`LongTermDebtNoncurrent`	$99.00K	USD	Point-in-time
Long-term debt payable, less current portion	`LongTermDebtNoncurrent`	$103.00K	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$1.11M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$1.65M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$3.87M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$3.42M	USD	Point-in-time
Series B convertible preferred stock, $.001 par value; 3 shares authorized, 2 and 2 shares issued and outstanding as of March 31, 2014 and December 31, 2013, respectively (liquidation preference of $1.7 million and $2.1 million at March 31, 2014 and December 31, 2013, respectively)	`ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue`	$1.14M	USD	Point-in-time
Series B convertible preferred stock, $.001 par value; 3 shares authorized, 2 and 2 shares issued and outstanding as of March 31, 2014 and December 31, 2013, respectively (liquidation preference of $1.7 million and $2.1 million at March 31, 2014 and December 31, 2013, respectively)	`ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue`	$922.00K	USD	Point-in-time
Common stock, $.001 Par value; 145,000 shares authorized, 71,770 and 70,479 shares issued and outstanding as of March, 31 2014 and December 31, 2013, respectively	`CommonStockValue`	$71.00K	USD	Point-in-time
Common stock, $.001 Par value; 145,000 shares authorized, 71,770 and 70,479 shares issued and outstanding as of March, 31 2014 and December 31, 2013, respectively	`CommonStockValue`	$72.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$101.84M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$102.50M	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$132.00K	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$132.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-103.03M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-104.64M	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.27M	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-107.00K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$2.60M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$3.32M	USD	Point-in-time

Income Statement 40 line items

Line Item	Tag	Value	Unit	Period
Contract and grant revenue	`Revenues`	$167.00K	USD	1 Quarter
Contract and grant revenue	`Revenues`	$19.00K	USD	1 Quarter
Sales - devices and disposables	`SalesDevicesAndDisposables`	$132.00K	USD	1 Quarter
Sales - devices and disposables	`SalesDevicesAndDisposables`	$122.00K	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$158.00K	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$192.00K	USD	1 Quarter
Gross Loss	`GrossProfit`	$-26.00K	USD	1 Quarter
Gross Loss	`GrossProfit`	$-70.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$607.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$813.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$164.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$283.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.04M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.14M	USD	1 Quarter
Total	`OperatingExpenses`	$2.02M	USD	1 Quarter
Total	`OperatingExpenses`	$2.03M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-1.88M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-2.08M	USD	1 Quarter
Other income	`OtherIncome`	$75.00K	USD	1 Quarter
Other income	`OtherIncome`	$2.00K	USD	1 Quarter
INTEREST EXPENSE	`InterestExpense`	$15.00K	USD	1 Quarter
INTEREST EXPENSE	`InterestExpense`	$27.00K	USD	1 Quarter
Change in fair value of warrants	`DerivativeGainLossOnDerivativeNet`	-	USD	1 Quarter
Change in fair value of warrants	`DerivativeGainLossOnDerivativeNet`	$542.00K	USD	1 Quarter
Total other income	`TotalOtherIncome`	$517.00K	USD	1 Quarter
Total other income	`TotalOtherIncome`	$60.00K	USD	1 Quarter
LOSS FROM OPERATIONS	`LossBeforeIncomeTaxes`	$1.56M	USD	1 Quarter
LOSS FROM OPERATIONS	`LossBeforeIncomeTaxes`	$1.81M	USD	1 Quarter
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	1 Quarter
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-1.81M	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-1.56M	USD	1 Quarter
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	$48.00K	USD	1 Quarter
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	-	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.61M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.81M	USD	1 Quarter
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	1 Quarter
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	63,671.00	shares	1 Quarter
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	71,451.00	shares	1 Quarter

Cash Flow Statement 56 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-1.81M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.56M	USD	1 Quarter
Bad debt expense (recovery)	`BadDebtRecovery`	$7.00K	USD	1 Quarter
Bad debt expense (recovery)	`BadDebtRecovery`	-	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$117.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$112.00K	USD	1 Quarter
Stock based compensation	`ShareBasedCompensation`	$359.00K	USD	1 Quarter
Stock based compensation	`ShareBasedCompensation`	$430.00K	USD	1 Quarter
Change in fair value of warrants	`ChangeInFairValueOfWarrants`	$-541.00K	USD	1 Quarter
Change in fair value of warrants	`ChangeInFairValueOfWarrants`	-	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	$85.00K	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	$-61.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-65.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$11.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-49.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$53.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-30.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$41.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$377.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$113.00K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-8.00K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$25.00K	USD	1 Quarter
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$255.00K	USD	1 Quarter
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-126.00K	USD	1 Quarter
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$502.00K	USD	1 Quarter
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$603.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInContinuingOperations`	$-1.31M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInContinuingOperations`	$-959.00K	USD	1 Quarter
Additions to fixed assets	`PaymentsToAcquirePropertyPlantAndEquipment`	$101.00K	USD	1 Quarter
Additions to fixed assets	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.00K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-101.00K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-4.00K	USD	1 Quarter
Proceeds from debt financing	`ProceedsFromIssuanceOfDebt`	$378.00K	USD	1 Quarter
Proceeds from debt financing	`ProceedsFromIssuanceOfDebt`	-	USD	1 Quarter
Payments made on notes payable	`PaymentsOfLoanCosts`	$45.00K	USD	1 Quarter
Payments made on notes payable	`PaymentsOfLoanCosts`	$169.00K	USD	1 Quarter
Proceeds from options and warrants exercised	`ProceedsFromWarrantExercises`	$67.00K	USD	1 Quarter
Proceeds from options and warrants exercised	`ProceedsFromWarrantExercises`	$1.65M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.48M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$400.00K	USD	1 Quarter
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$65.00K	USD	1 Quarter
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-563.00K	USD	1 Quarter
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$613.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$1.04M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$50.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$1.11M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$613.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.04M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$50.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.11M	USD	Point-in-time
Cash paid for Interest	`InterestPaid`	$4.00K	USD	1 Quarter
Cash paid for Interest	`InterestPaid`	$8.00K	USD	1 Quarter
Conversion of accrued expenses into common stock / options	`DeemedDividendsInFormOfConvertibleWarrantsIntoCommonStock`	$22.00K	USD	1 Quarter
Conversion of accrued expenses into common stock / options	`DeemedDividendsInFormOfConvertibleWarrantsIntoCommonStock`	-	USD	1 Quarter
Issuance of common stock as board compensation	`IssuanceOfCommonStockAsBoardCompensation`	-	USD	1 Quarter
Issuance of common stock as board compensation	`IssuanceOfCommonStockAsBoardCompensation`	$463.00K	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.